ReviewCurrent pain and headache reports2014
Breakthrough cancer pain.
Review in Current pain and headache reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 29 citations in OpenAlex.
- Trial
- [Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate].Schmerz (Berlin, Germany) · 2016Trial
- A scoping review of breakthrough cancer pain: mapping the evidence landscape.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Breakthrough cancer pain: assessment and self-management perspectives among oncology nurses.BMC nursing · 2025Article
- Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain.BMC palliative care · 2024Article
- Article
- Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients.Journal of thoracic disease · 2023Article
- Management of pain in patients with bone metastases.Frontiers in oncology · 2023Review
- Bayesian Network Analysis for Prediction of Unplanned Hospital Readmissions of Cancer Patients with Breakthrough Cancer Pain and Complex Care Needs.Healthcare (Basel, Switzerland) · 2022Article
- Light-Induced Activation of a Specific Type-5 Metabotropic Glutamate Receptor Antagonist in the Ventrobasal Thalamus Causes Analgesia in a Mouse Model of Breakthrough Cancer Pain.International journal of molecular sciences · 2022Article
- Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.The oncologist · 2019Article
- Canadian recommendations for the management of breakthrough cancer pain.Current oncology (Toronto, Ont.) · 2016Article
- Pharmacologic management of adult breakthrough cancer pain.Canadian family physician Medecin de famille canadien · 2014Article
- Response to letter to the editor: "safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study".Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breakthrough pain is a distinct pain state that is common in patients with cancer pain and which is associated with significant morbidity in this group of patients. The aim of this article is to highlight important journal articles relating to breakthrough pain that have been published within the last year, including a systematic review of the epidemiology of breakthrough pain, the largest-ever study of the clinical features of breakthrough pain, and a network meta-analysis of the treatment of breakthrough pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.